The American Heart of Poland Group (supported by Gruppo San Donato Italy and GKSD Srl) received approval from the President of the Office of Competition and Consumer Protection on November 12, 2024, to finalize a transaction to take control of the Scanmed Group in Poland, which comprises over 30 medical facilities, including four multispecialty hospitals, three monoclincs, cardiology wards, and a network of primary healthcare clinics and outpatient specialist care.
The President of the Office of Competition and Consumer Protection emphasized in the rationale for the decision that “AHP’s aim is to increase its presence in new locations as well as in new medical specialties. AHP is interested in long-term stable development in the Polish healthcare market.”
Upon receiving permission from the Office of Competition and Consumer Protection, the American Heart of Poland Group will finalize the transaction to take control over the Scanmed Group. AHP, part of Gruppo San Donato Italy (GSD) and GKSD Srl, specializing in the coordinated diagnosis, treatment, and rehabilitation of civilization diseases, will double the size of its operations in the public healthcare sector. This will significantly expand its geographical coverage, offering medical care to approximately 600,000 patients annually after the merger. This is another step in the development of the American Heart of Poland Group within the public healthcare system in Poland, supported by the leading European medical group – Gruppo San Donato.
Approaching its 25th anniversary, the American Heart of Poland Group has been gradually increasing the number of facilities – since 2022, it has been managing a hospital in Drawsko Pomorskie, and since 2023, it has also been managing a multi-profile hospital in Sztum. Taking over control of the Scanmed Group is another important stage in the development strategy of the American Heart of Poland Group, and GSD, which specializes in all segments of advanced medical care, thereby earns its leading research and educational base on the continent.
The Scanmed Group is a leading medical operator in terms of the range of services provided. Scanmed offers medical care in more than 30 locations, for over 300,000 patients annually across Poland. Scanmed’s activities include primary healthcare, outpatient specialist care, and hospital treatment. Scanmed has a network of cardiology centers located across 8 provinces, providing comprehensive diagnostics and hospital treatment for cardiovascular diseases within the framework of conservative, interventional, and electrophysiology cardiology. Scanmed also operates four multispecialty hospitals – St. Raphael Hospital in Krakow, Rudolf Weigl Hospital in Blachownia, Vital Medic Hospital in Kluczbork, and Ars Medical in Pila. Scanmed also runs three specialist monoclincs: gastroenterology, ophthalmology, and orthopedics. The complementary to Scanmed Group’s hospital operations are the medical centers offering patients access to primary healthcare, modern diagnostics, and outpatient specialist care.
In the public healthcare system, the American Heart of Poland Group provides comprehensive, multispecialty medical care in over 20 medical centers, combining health education, prevention, diagnosis, treatment, and rehabilitation of civilization diseases. The group provides over 260,000 patients annually with access to high-class medical procedures under a contract with the National Health Fund. The entities belonging to the group carry out 73,000 hospitalizations annually, related in particular to coronary procedures, arrhythmia and conduction disorders, and heart failure.
The Gruppo San Donato is the largest Italian and leading European private group within the healthcare sector, specializing in emergency care, medical education, and research. It operates 136 medical facilities, world-leading hospitals with teaching and research activities, the Vita Salute San Raffaele University in Milan with 22 Master’s programs and doctoral-level education, as well as medical research that ranks in the top ten worldwide (according to medical research citations). The Gruppo San Donato is also a pioneer in gene and cell therapy worldwide. GSD treats over 5.8 million patients annually and employs over 28,000 staff.
GKSD manages a diversified portfolio of companies operating in Italy, which generate added value for their stakeholders, utilizing their unique know-how. GKSD focuses on multiple sectors, including purchasing and healthcare consulting, real estate market, engineering, and energy.
Source: https://managerplus.pl/grupa-american-heart-of-poland-przejmuje-kontrole-nad-grupa-scanmed-zgoda-prezesa-uokik-na-najwieksza-transakcje-w-polskiej-ochronie-zdrowia-90707
